Table 3. Absolute inflammatory marker concentrations before atorvastatin treatment and changes during atorvastatin treatment.

		Baseline	Week 12	Week 24	Week 48
IL-6 (pg/mL)	N	27	24	23	24
	Mean (s.d.)	1.83 (1.53)	2.27 (1.71)	1.53 (1.09)	2.63 (4.92)
	Median (Min, Max)	1.66 (0.47, 7.94)	1.94 (0.51, 6.97)	1.36 (0.42, 4.41)	1.15 (0.56, 24.56)
	Mean % change (90% CI)		62.1 (11.6, 112.6)	-1.3 (-22, 19.4)	40.2 (-6, 86.4)
	Median % change (90% CI)		-1 (-32, 110)	-19 (-32, -5)	-11.5 (-34, 46)
hs-CRP (mg/L)	N	27	25	23	24
	Mean (s.d.)	4.32 (5.97)	4.14 (6.18)	1.91 (3.92)	1.88 (4.05)
	Median (Min, Max)	1.20 (0.20, 22.00)	1.00 (0.20, 20.50)	0.50 (0.20, 18.90)	0.60 (0.20, 19.30)
	Mean % change (90% CI)		132.2 (23.5, 240.9)	-9.8 (-43.3, 23.7)	20.4 (-33.8, 74.6)
	Median % change (90% CI)		0 (-35, 44)	-20 (-67, 0)	0 (-78, 17)

IL-6= interleukin-6 hs-CRP= highly sensitive C-reactive protein s.d.= standard deviation CI= confidence interval